Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Cost of Healthcare

Alcohol, Drugs, Homelessness and Crime

Posted on June 23, 2022 by John C. Goodman

Scott Alexander reviews Michael Shellenberger’s San Fransicko:

putting it all together and squinting really hard, I think we can tell a story where 10-20% of the homeless are seriously psychotic, and another 20-30% have contributing mental health conditions including depression, PTSD, and others. Somewhere between 25% and 50% of the homeless have substance abuse problems, and this probably mostly overlaps with the 25% – 50% who have psych diagnoses.

+

Thursday Links

Posted on June 23, 2022July 25, 2022 by John C. Goodman

HHS says it doesn’t have time to review itself.

  • House panel attacks Scott Atlas. The problem: Atlas was right and the critics were wrong.
  • More Covid fraud: As much as 20% of funds for small business may have gone to scammers.
  • Paragon Health study: make HSAs an option in Obamacare.
  • What if the government stopped paying 80% of the premium for higher income folks? 3 million would stop buying the insurance.
    +
  • FTC to Fight Drug Rebates and Fees that Reduce Competition

    Posted on June 22, 2022June 22, 2022 by Devon Herrick

    On June 16, 2022 the U.S. Federal Trade Commission (FTC) issued a policy statement on drug rebates and fees paid by drug makers. The rebates and fee are paid to Pharmacy Benefit Managers (PBMs) sometimes in return for excluding cheaper alternatives on a drug plan formulary. The way it works is a drug maker will jack up the price of a given drug (like insulin) but give a steep discount to the PBM in return for guarantees that the plan will not include generic versions that cost far lesson the formulary.

    +

    Wednesday Links

    Posted on June 22, 2022July 25, 2022 by John C. Goodman
    • Harvard Study: Medicare could save $3.6 billion a year by taking advantage of Mark Cuban’s new mail order pharmacy.
    • Nearly 1 in 4 women in the United States will have an abortion by the age of 45; and almost 93 percent are performed before the 13th week.
    •  “The greatest heist of American taxpayer dollars in history.” They’re talking about Covid money lost to fraud.
    • In Texas, physicians who earn a “gold card” no longer have to endure the hassles of prior authorization.
    • The part of covid that’s not over: every large city is below 50% of its office space being occupied.
    +
    • Previous
    • 1
    • …
    • 304
    • 305
    • 306
    • 307
    • 308
    • 309
    • 310
    • …
    • 326
    • Next

    For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

    During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

    John C. Goodman,

    Visit www.goodmaninstitute.org

    Subscribe via Email

    Enter your email address to subscribe to this blog and receive notifications of new posts by email.

    Join 35 other subscribers

    Popular Topics

    ©2025 The Goodman Institute Health Blog | Website by Lexicom